Arbutus Biopharma Corp (ABUS) Ownership

$4.17

$0.01 (-0.12%)
Last update: 02:26 PM EST
Day's range
$4.07
Day's range
$4.3

Arbutus Biopharma Corp Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
MORGAN STANLEY 02/13/2026 26.70 M $128.44 M   9.21% 13.92%
BLACKROCK, INC. 02/12/2026 13.05 M $62.78 B   2.96% 6.81%
TWO SEAS CAPITAL LP 02/11/2026 12.59 M $60.55 M   14.54% 6.56%
VANGUARD GROUP INC 01/29/2026 9.24 M $44.46 M   2.80% 4.82%
STATE STREET CORP 02/13/2026 5.91 M $28.42 M   44.16% 3.08%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 3.68 M $17.69 M   0.30% 1.92%
RUBRIC CAPITAL MANAGEMENT LP 02/13/2026 1.58 M $7.58 M   0.00% 0.82%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 1.56 M $7.51 M   22.55% 0.81%
ADVISOR GROUP HOLDINGS, INC. 02/17/2026 1.35 M $6.48 B   0.73% 0.70%
UBS ASSET MANAGEMENT AMERICAS INC 02/13/2026 890.90 K $4.29 M   100.00% 0.46%
BANK OF MONTREAL /CAN/ 02/12/2026 766.66 K $3.69 M   0.18% 0.40%
GOLDMAN SACHS GROUP INC 02/10/2026 738.58 K $3.55 M   -66.02% 0.39%
HUDSON BAY CAPITAL MANAGEMENT LP 02/13/2026 675.00 K $3.25 M   -15.63% 0.35%
CITIGROUP INC 02/13/2026 620.00 K $2.98 M   -26.63% 0.32%
CITIGROUP INC 02/13/2026 611.15 K $2.94 M   208.91% 0.32%
AFFINITY ASSET ADVISORS, LLC 02/13/2026 521.90 K $2.51 M   146.76% 0.27%
QUINN OPPORTUNITY PARTNERS LLC 02/13/2026 514.51 K $2.47 M   0.00% 0.27%
WESTERN STANDARD LLC 02/03/2026 507.85 K $2.44 M   0.00% 0.26%
KENNEDY CAPITAL MANAGEMENT LLC 02/13/2026 505.09 K $2.43 M   0.00% 0.26%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 473.60 K $2.28 M   27.28% 0.25%
FREESTONE CAPITAL HOLDINGS, LLC 01/23/2026 442.50 K $2.13 M   0.00% 0.23%
BANK OF NEW YORK MELLON CORP 02/10/2026 387.91 K $1.87 M   -2.81% 0.20%
BARCLAYS PLC 02/13/2026 356.68 K $1.72 M   25.45% 0.19%
SABA CAPITAL MANAGEMENT, L.P. 02/17/2026 347.89 K $1.67 M   -48.75% 0.18%
CITIGROUP INC 02/13/2026 339.20 K $1.63 M   -22.77% 0.18%
SWISS NATIONAL BANK 02/12/2026 283.40 K $1.36 M   2.57% 0.15%
LEDGEWOOD WEALTH ADVISORS, LLC 01/16/2026 278.44 K $1.34 M   0.00% 0.15%
NUVEEN, LLC 02/12/2026 257.93 K $1.24 B   0.00% 0.13%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 192.20 K $924.48 K   628.03% 0.10%
RHUMBLINE ADVISERS 02/13/2026 183.25 K $881.42 K   -13.47% 0.10%
WELLS FARGO & COMPANY/MN 02/13/2026 167.02 K $803.37 K   74.98% 0.09%
NOMURA HOLDINGS INC 02/17/2026 150.00 K $721.50 K   0.00% 0.08%
UBS GROUP AG 01/29/2026 147.29 K $708.48 M   -80.98% 0.08%
DEUTSCHE BANK AG\ 02/11/2026 140.20 K $674.35 K   6.35% 0.07%
ZURCHER KANTONALBANK (ZURICH CANTONALBANK) 01/27/2026 128.32 K $617.20 K   27.88% 0.07%
WEALTH MANAGEMENT ASSOCIATES, INC. 01/20/2026 127.87 K $615.06 K   13.34% 0.07%
LEGAL & GENERAL GROUP PLC 02/09/2026 122.76 K $590.48 K   -1.14% 0.06%
SCHRODER INVESTMENT MANAGEMENT GROUP 02/13/2026 121.31 K $560.47 K   0.00% 0.06%
RAFFERTY ASSET MANAGEMENT, LLC 02/13/2026 117.03 K $562.92 K   120.78% 0.06%
CAMPBELL & CO INVESTMENT ADVISER LLC 02/12/2026 113.11 K $544.07 K   54.35% 0.06%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 109.41 K $526.27 K   70.44% 0.06%
CITADEL ADVISORS LLC 02/17/2026 104.84 K $504.30 K   -45.87% 0.05%
NOMURA HOLDINGS INC 02/17/2026 98.10 K $471.86 K   -1.90% 0.05%
JPMORGAN CHASE & CO 02/11/2026 97.88 K $470.78 K   -0.36% 0.05%
JANE STREET GROUP, LLC 02/12/2026 83.93 K $403.72 M   -72.06% 0.04%
ENTRYPOINT CAPITAL, LLC 02/12/2026 75.61 K $363.67 K   161.94% 0.04%
EXOME ASSET MANAGEMENT LLC 02/13/2026 75.48 K $363.08 K   0.00% 0.04%
CLEAR HARBOR ASSET MANAGEMENT, LLC 02/10/2026 74.76 K $359.60 K   0.00% 0.04%
METLIFE INVESTMENT MANAGEMENT, LLC 02/12/2026 73.24 K $352.27 K   -16.64% 0.04%
INTECH INVESTMENT MANAGEMENT LLC 02/10/2026 70.56 K $339.41 K   48.59% 0.04%

Arbutus Biopharma Corp institutional Ownership - FAQ's

During the previous two years, 174 institutional investors and hedge funds held shares of Arbutus Biopharma Corp. The most heavily invested institutionals were:

MORGAN STANLEY: 26.7 M

BlackRock, Inc.: 13.05 M

Two Seas Capital LP: 12.59 M

VANGUARD GROUP INC: 9.24 M

STATE STREET CORP: 5.91 M

GEODE CAPITAL MANAGEMENT, LLC: 3.68 M

23.24% of Arbutus Biopharma Corp stock is owned by institutional investors.

Institutional investors have bought a total of 100.42 M shares in the last 24 months. This purchase volume represents approximately $418.74 M in transactions.